Prevention and adjuvant treatment of actinic keratosis (AK) and other forms of non-melanoma cancer (NMSC).
Reduces and improves the subclinical carcinoma field associated with actinic keratosis and non-melanoma skin cancer.
With DNA Repairsomes, a technology patented by ISDIN that reduces and improves the field of subclinical skin carcinomaization associated with actinic keratosis and non-melanoma skin cancer.
Prevents and promotes the repair of actinic damage caused by the sun. It deposits a protective film of Repairsomes® DNA (UVB 109, UVA 39) on the skin, which helps prevent the appearance of new lesions.
Furthermore, continued use stimulates the natural DNA repair mechanism.